These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 10422027)
1. Prevention of heterotopic ossification in hip arthroplasty. The influence of the duration of treatment. Vastel L; Kerboull L; Dejean O; Courpied JP; Kerboull M Int Orthop; 1999; 23(2):107-10. PubMed ID: 10422027 [TBL] [Abstract][Full Text] [Related]
2. The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement. Pakos EE; Tsekeris PG; Paschos NK; Pitouli EJ; Motsis EK; Xenakis TA J BUON; 2010; 15(1):74-8. PubMed ID: 20414931 [TBL] [Abstract][Full Text] [Related]
3. Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment. Dorn U; Grethen C; Effenberger H; Berka H; Ramsauer T; Drekonja T Acta Orthop Scand; 1998 Apr; 69(2):107-10. PubMed ID: 9602763 [TBL] [Abstract][Full Text] [Related]
4. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty. van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398 [TBL] [Abstract][Full Text] [Related]
5. Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty. Amstutz HC; Fowble VA; Schmalzried TP; Dorey FJ J Arthroplasty; 1997 Feb; 12(2):126-32. PubMed ID: 9139094 [TBL] [Abstract][Full Text] [Related]
6. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. Grohs JG; Schmidt M; Wanivenhaus A Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399 [TBL] [Abstract][Full Text] [Related]
7. Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty. van der Heide HJ; Koorevaar RT; Schreurs BW; van Kampen A; Lemmens A J Arthroplasty; 1999 Oct; 14(7):796-9. PubMed ID: 10537252 [TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam. Barthel T; Baumann B; Nöth U; Eulert J Acta Orthop Scand; 2002 Dec; 73(6):611-4. PubMed ID: 12553505 [TBL] [Abstract][Full Text] [Related]
10. Naproxen in the prevention of heterotopic ossification after total hip replacement. Vielpeau C; Joubert JM; Hulet C Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis for heterotopic ossification after primary total hip arthroplasty. A cohort study between indomethacin and meloxicam. van der Heide HJ; Spruit M; Slappendel R; Klooster N; van Limbeek J Acta Orthop Belg; 2004 Jun; 70(3):240-6. PubMed ID: 15287403 [TBL] [Abstract][Full Text] [Related]
12. General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty. Hofmann S; Trnka HJ; Metzenroth H; Frank E; Ritschl P; Salzer M Orthopedics; 1999 Feb; 22(2):207-11. PubMed ID: 10037334 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement. Kölbl O; Knelles D; Barthel T; Kraus U; Flentje M; Eulert J Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):961-6. PubMed ID: 9392532 [TBL] [Abstract][Full Text] [Related]
14. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty. Legenstein R; Bösch P; Ungersböck A Arch Orthop Trauma Surg; 2003 Apr; 123(2-3):91-4. PubMed ID: 12664317 [TBL] [Abstract][Full Text] [Related]
15. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong]. Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138 [TBL] [Abstract][Full Text] [Related]
16. Indomethacin versus radiation therapy for heterotopic ossification after hip arthroplasty. D'Lima DD; Venn-Watson EJ; Tripuraneni P; Colwell CW Orthopedics; 2001 Dec; 24(12):1139-43. PubMed ID: 11770090 [TBL] [Abstract][Full Text] [Related]
17. Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol. Pakos EE; Pitouli EJ; Tsekeris PG; Papathanasopoulou V; Stafilas K; Xenakis TH Int Orthop; 2006 Apr; 30(2):79-83. PubMed ID: 16482442 [TBL] [Abstract][Full Text] [Related]
18. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. Romanò CL; Duci D; Romanò D; Mazza M; Meani E J Arthroplasty; 2004 Jan; 19(1):14-8. PubMed ID: 14716644 [TBL] [Abstract][Full Text] [Related]
19. [Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty]. Gebuhr PH; Wilbek H; Soelberg M Ugeskr Laeger; 1996 Feb; 158(8):1076-8. PubMed ID: 8638341 [TBL] [Abstract][Full Text] [Related]
20. Prevention of heterotopic ossification after total hip replacement: a prospective comparison of indomethacin and salmon calcitonin in 60 patients. Günal I; Hazer B; Seber S; Göktürk E; Turgut A; Köse N Acta Orthop Scand; 2001 Oct; 72(5):467-9. PubMed ID: 11728072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]